News
China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback